BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29959198)

  • 1. Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.
    Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Omori T; Nakanishi K; Fujimura J; Ashida A; Kitamura M; Kawano M; Shimabukuro W; Kitabayashi C; Imafuku A; Tamagaki K; Kamei K; Okamoto K; Fujinaga S; Oka M; Igarashi T; Miyazono A; Sawanobori E; Fujimaru R; Nakanishi K; Shima Y; Matsuo M; Ye MJ; Nozu Y; Morisada N; Kaito H; Iijima K
    J Am Soc Nephrol; 2018 Aug; 29(8):2244-2254. PubMed ID: 29959198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked Alport syndrome caused by splicing mutations in COL4A5.
    Nozu K; Vorechovsky I; Kaito H; Fu XJ; Nakanishi K; Hashimura Y; Hashimoto F; Kamei K; Ito S; Kaku Y; Imasawa T; Ushijima K; Shimizu J; Makita Y; Konomoto T; Yoshikawa N; Iijima K
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1958-64. PubMed ID: 25183659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome.
    Di H; Zhang J; Gao E; Zheng C; Huang X; Wang Q; Yu X; Liu Z
    Nephrol Dial Transplant; 2022 Nov; 37(12):2487-2495. PubMed ID: 35020912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mosaicism is a pitfall in the diagnosis of "sporadic" X-linked Alport syndrome.
    Okamoto T; Nozu K; Iijima K; Ariga T
    J Nephrol; 2019 Feb; 32(1):155-159. PubMed ID: 30062677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlation in X-linked Alport syndrome.
    Bekheirnia MR; Reed B; Gregory MC; McFann K; Shamshirsaz AA; Masoumi A; Schrier RW
    J Am Soc Nephrol; 2010 May; 21(5):876-83. PubMed ID: 20378821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
    Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Functional Analysis in vitro of 2 COL4A5 Splicing Mutations at the Same Site in 2 Unrelated Alport Syndrome Chinese Families.
    Lv X; Wu WQ; Zhang JX; Miao LF; Yu BZ; Chen FF; Cui YX; Xia ZK; Liu ZH; Li XJ
    Cytogenet Genome Res; 2020; 160(5):238-244. PubMed ID: 32659759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.
    Horinouchi T; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Ishimori S; Kaito H; Matsuo M; Iijima K; Nozu K
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1342. PubMed ID: 32543079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal macular thinning associated with X-linked Alport syndrome.
    Ahmed F; Kamae KK; Jones DJ; Deangelis MM; Hageman GS; Gregory MC; Bernstein PS
    JAMA Ophthalmol; 2013 Jun; 131(6):777-82. PubMed ID: 23572034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation of X-linked Alport syndrome observed in both genders: a multicenter study in South Korea.
    Kim JH; Lim SH; Song JY; Cho MH; Hyun H; Yang EM; Lee JW; Cho MH; Park MJ; Lee JH; Jung J; Yoo KH; Jang KM; Pai KS; Suh JS; Namgoong MK; Chung WY; Kim SJ; Cho EY; Kim KM; Kim NH; Kim M; Paik JH; Kang HG; Ahn YH; Cheong HI
    Sci Rep; 2023 Apr; 13(1):6827. PubMed ID: 37100867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
    Tazón-Vega B; Ars E; Burset M; Santín S; Ruíz P; Fernández-Llama P; Ballarín J; Torra R
    Am J Kidney Dis; 2007 Aug; 50(2):257.e1-14. PubMed ID: 17660027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of clinical characteristics and genetic backgrounds in Alport syndrome.
    Nozu K; Nakanishi K; Abe Y; Udagawa T; Okada S; Okamoto T; Kaito H; Kanemoto K; Kobayashi A; Tanaka E; Tanaka K; Hama T; Fujimaru R; Miwa S; Yamamura T; Yamamura N; Horinouchi T; Minamikawa S; Nagata M; Iijima K
    Clin Exp Nephrol; 2019 Feb; 23(2):158-168. PubMed ID: 30128941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
    Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
    CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females.
    Wang Y; Zhang H; Ding J; Wang F
    Exp Biol Med (Maywood); 2007 May; 232(5):638-42. PubMed ID: 17463160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis and genetic counseling of X-linked Alport syndrome in China].
    Zhang HW; Ding J; Wang F; Yang HX
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):484-9. PubMed ID: 17953801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay.
    Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Kaito H; Matsuo M; Iijima K
    Sci Rep; 2019 Sep; 9(1):12696. PubMed ID: 31481700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.